For: | Liu T, Xie XL, Zhou X, Chen SX, Wang YJ, Shi LP, Chen SJ, Wang YJ, Wang SL, Zhang JN, Dou SY, Jiang XY, Cui RL, Jiang HQ. Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma. World J Gastroenterol 2021; 27(28): 4667-4686 [PMID: 34366628 DOI: 10.3748/wjg.v27.i28.4667] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i28/4667.htm |
Number | Citing Articles |
1 |
Hai-Yan Zhang, Jia-Jie Zhu, Zong-Ming Liu, Yu-Xuan Zhang, Jia-Jia Chen, Ke-Da Chen. A prognostic four-gene signature and a therapeutic strategy for hepatocellular carcinoma: Construction and analysis of a circRNA-mediated competing endogenous RNA network. Hepatobiliary & Pancreatic Diseases International 2024; 23(3): 272 doi: 10.1016/j.hbpd.2023.06.009
|
2 |
Yuting Yin, Chun Wu, Yufeng Zhou, Meiyin Zhang, Shijuan Mai, Minshan Chen, Hui-Yun Wang. Ezetimibe Induces Paraptosis through Niemann–Pick C1-like 1 Inhibition of Mammalian-Target-of-Rapamycin Signaling in Hepatocellular Carcinoma Cells. Genes 2023; 15(1): 4 doi: 10.3390/genes15010004
|
3 |
Rok Razpotnik, Robert Vidmar, Marko Fonović, Damjana Rozman, Tadeja Režen. Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma. Cancers 2022; 14(18): 4524 doi: 10.3390/cancers14184524
|
4 |
Jia‐heng Xing, Ru‐xue Tan, Fei‐er Huang, Nan Tian. Integrated analyses for identification of a three‐gene signature associated with Chaihu Shugan San formula for hepatocellular carcinoma treatment. Journal of Cellular and Molecular Medicine 2024; 28(8) doi: 10.1111/jcmm.18211
|
5 |
Ganghui Ye. Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review). American Journal of Cancer Research 2024; 14(9): 4113 doi: 10.62347/UJVP4361
|
6 |
Yanfeng Wang, Yuhan Cao, Yingcong Wang, Junwei Sun, Lidong Wang, Xin Song, Xueke Zhao. Construction and analysis of protein-protein interaction network for esophageal squamous cell carcinoma. Computers in Biology and Medicine 2024; 182: 109156 doi: 10.1016/j.compbiomed.2024.109156
|
7 |
Ting Liu, Congjie Zhai, Bo Tian, Chao Li, Shuangshuang Han, Shihui Wang, Mingda Xuan, Dehua Liu, Yunxia Zhao, Hongyan Zhao, Weifang Yu, Jia Wang. Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with Y-box binding protein 1. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53013-3
|
8 |
Ouwen Li, Ke An, Han Wang, Xianbin Li, Yueqin Wang, Lan Huang, Yue Du, Nuo Qin, Jiasheng Dong, Jingyao Wei, Ranran Sun, Yong Shi, Yanjia Guo, Xiangyi Sun, Ying Yang, Yun‐Gui Yang, Quancheng Kan, Xin Tian. Targeting YBX1‐m5C mediates RNF115 mRNA circularisation and translation to enhance vulnerability of ferroptosis in hepatocellular carcinoma. Clinical and Translational Medicine 2025; 15(3) doi: 10.1002/ctm2.70270
|
9 |
Xiaodong Li, Xuedong Yin, Heyi Bao, Chang Liu. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway. Molecular and Cellular Probes 2023; 67: 101877 doi: 10.1016/j.mcp.2022.101877
|
10 |
Xiaoju Huang, Mengmeng Wang, Dan Zhang, Junpeng Meng, Pian Liu. ZDHHC20 Activates AKT Signaling Pathway to Promote Cell Proliferation in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 1763 doi: 10.2147/JHC.S457682
|
11 |
Chenglian Hu, Ying Yang, Lun Ye. miR-10a Ameliorates Renal and Myocardial Injury in Sepsis Through Regulation of PI3K/AKT Signaling. Journal of Biomaterials and Tissue Engineering 2023; 13(2): 301 doi: 10.1166/jbt.2023.3255
|